Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Monascus purpureus ferment
Chinese fermented rice with natural monacolin K (lovastatin).
Red yeast rice is a traditional Chinese fermented rice product (Monascus purpureus) containing monacolin K, a naturally occurring HMG-CoA reductase inhibitor identical to lovastatin. It is primarily used for lowering LDL cholesterol and supporting cardiovascular health. Key active compounds include monacolin K, monascin, ankaflavin, and dimerumic acid.
Monacolin K competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, thereby reducing hepatic cholesterol production and upregulating LDL receptor expression to enhance clearance of circulating LDL. Additional compounds such as monascin and ankaflavin exhibit anti-inflammatory and antioxidant activities via NF-κB inhibition and Nrf2 activation, though their clinical relevance is less established. Dimerumic acid may contribute to hepatoprotective effects through free radical scavenging.
Chinese fermented rice with natural monacolin K (lovastatin).
Red yeast rice is a traditional Chinese fermented rice product (Monascus purpureus) containing monacolin K, a naturally occurring HMG-CoA reductase inhibitor identical to lovastatin. It is primarily used for lowering LDL cholesterol and supporting cardiovascular health. Key active compounds include monacolin K, monascin, ankaflavin, and dimerumic acid.
Monacolin K competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, thereby reducing hepatic cholesterol production and upregulating LDL receptor expression to enhance clearance of circulating LDL. Additional compounds such as monascin and ankaflavin exhibit anti-inflammatory and antioxidant activities via NF-κB inhibition and Nrf2 activation, though their clinical relevance is less established. Dimerumic acid may contribute to hepatoprotective effects through free radical scavenging.